
Clorox (CLX) Stock Forecast & Price Target
Clorox (CLX) Analyst Ratings
Bulls say
Clorox has demonstrated strong financial performance, exceeding internal expectations primarily due to robust sales growth in its Health & Wellness and International segments, with a notable 16.4% increase in consumption reported in recent sales data. The company's earnings per share also surpassed consensus estimates at $1.86, signaling solid profitability amid competitive pressures. Additionally, Clorox continues to improve market shares across most of its businesses for the second consecutive quarter and is positioned for growth through impactful innovation and recovery from recent cybersecurity challenges.
Bears say
Clorox faces a challenging operating environment, with management projecting minimal organic growth in the low single digits (+0-1%), primarily due to difficult comparisons from the previous year’s recovery following a cyberattack. The company is experiencing supply chain issues in specific categories such as bags and cat litter, which have resulted in slower performance recovery compared to other product lines. Additionally, Clorox is at risk from fluctuating input costs for raw materials and labor, and the highly competitive nature of the consumer products sector further complicates its ability to maintain profitability and sales levels.
This aggregate rating is based on analysts' research of Clorox and is not a guaranteed prediction by Public.com or investment advice.
Clorox (CLX) Analyst Forecast & Price Prediction
Start investing in Clorox (CLX)
Order type
Buy in
Order amount
Est. shares
0 shares